What does NeoGenomics, Inc. do?

Jun 22 2025 06:39 PM IST
share
Share Via
NeoGenomics, Inc. operates cancer-focused genetic testing laboratories and reported net sales of $168 million with a net loss of $26 million as of March 2025. The company has a market cap of $899.57 million and a debt-to-equity ratio of 0.21.
Overview:
NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories in the Pharmaceuticals & Biotechnology industry, categorized as a small-cap company. Financial Snapshot: Net Sales: 168 Million (Quarterly Results - Mar 2025) Net Profit: -26 Million (Quarterly Results - Mar 2025) Market cap: USD 899.57 Million (Small Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.21 Return on Equity: -7.07% Price to Book: 1.01 Contact Details: Address: 12701 Commonwealth Dr Ste 9, FORT MYERS FL: 33913-8626 Tel: ['1 941 9231949', '1 239 6904239'] Fax: 1 775 3290852 Website: https://neogenomics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News